- Fee assured
- Verified account
Dr Arnab Datta qualified from Jesus College, Cambridge with a first class degree in Neurophysiology, before completing his medical training at University College, London (UCL), graduating with a Distinction and several University prizes. He trained at several of the country’s top teaching hospitals, including The Royal Brompton Hospital and St Mary’s Hospital, before being award a prestigious Wellcome Trust Fellowship (2008) and completing his PhD (pulmonary fibrosis) at UCL (2011).
Dr Datta was appointed as a Consultant in Respiratory Medicine at Northwick Park Hospital in 2012, and is an an Honorary Consultant at Imperial College Healthcare NHS Trust (St Mary’s Hospital) in Interstitial Lung Disease (ILD). He has a specialist interest in ILD including lung fibrosis, and is Clinical Lead for ILD at Northwick Park Hospital - in this field, he has published in peer-reviewed journals, and has an on-going interest in clinical research, involving collaboration with The Royal Brompton Hospital, as well as Imperial College. Recent work has focused on developing novel Patient Reported Experience Measures for patients with lung fibrosis, and hub and spoke pathways facilitating early diagnosis and treatment.
He is also the Lung Cancer Lead for London North West University Healthcare NHS Trust, managing the delivery of lung cancer services across Ealing, Central Middlesex Hospital and Northwick Park Hospital. Through case by case assessment of all referrals, and weekly coordination of care with oncologists and thoracic surgeons, he has increased the capacity of the Trust to see all patients within national targets, improving time to diagnosis and treatment.
As well as being a highly skilled bronchoscopist, he developed and expanded the Endobronchial Ultrasound (EBUS) service at Northwick Park Hospital which has further significantly reduced the waiting time to treatment of patients with lung cancer, tuberculosis and other significant lung diseases such as sarcoid.
He is additionally involved in managing the High Dependency Unit, directing the care of severely ill patients including those with respiratory failure, including COVID infections, and his expertise in lung fibrosis has proved critical in managing the sequelae of COVID pneumonia such as lung fibrosis.
Dr Datta’s clinical practice involves managing patients across the entire range of respiratory symptoms and conditions. He is consulted about cough, breathlessness and wheeze, as well as sputum production, coughing up blood (haemoptysis) and chest pain. He treats patients with chronic cough, asthma, COPD and lung cancer, as well as pleural conditions, including pleural effusions and pneumothoraces. His specialist interest is the management of patients with fibrotic lung disease, including idiopathic pulmonary fibrosis and sarcoid.
Areas of interest
breathlessness; cough; infection; bronchiectasis; fibrosis; lung cancer; COPD; emphysema; asthma; pleural disease (including effusions and pneumothorax); lung nodules; pulmonary emboli; sarcoid
- Dr Arnab Datta
Current NHS consultant posts held
Consultant Physician in Respiratory / High Dependency Medicine @ Northwick Park Hospital, London
Lung Cancer Lead at Northwick Park Hospital
ILD Lead at Northwick Park Hospital
Bronchoscopy/EBUS Lead at Northwick Park Hospital
Honorary Consultant in Respiratory Medicine
@ St Mary's Hospital, London
Awarded 5 CEA awards over past 4 years for outstanding improvements to patient care
Idiopathic Pulmonary Fibrosis
Connective tissue disease-related interstitial lung disease
Duckworth Prize - top mark in Tripos 1A , Cambridge (1994)
Perret Prize - top mark in Tripos 1B, Cambridge (1995)
Jesus College Cambridge Scholarships (1993-6)
Distinction in Medicine (MBBS) (1999)
Wellcome Trust Clinical Training Fellowship (2008)
PhD (University College, London 2011)
Clinical Science Prize (Royal Society of Medicine, 2012)
Development of an Idiopathic Pulmonary Fibrosis Patient Reported Experience Measure.
Russel AM, Saketkoo LA, Datta A, Scholand MB, Newell K, Conway J, Jones S, Wickremasinghe M. European Respiratory Society 2019
Pneumonitis secondary to alemtuzumab in a patient with multiple sclerosis - A non-infectious cause of breathlessness.
Whiteside D, Barth S, Datta A, Trip SA
Mult Scler Relat Disord. 2018 May;22:139-140
Ex vivo micro-computed tomography analysis of bleomycin-induced lung fibrosis for preclinical drug evaluation.
Scotton CJ, Hayes B, Alexander R, Datta A, Forty EJ, Mercer PF, Blanchard A, Chambers RC. Eur Respir J. 2013 Dec;42(6):1633-45
Evidence for a functional thymic stromal lymphopoietin signaling axis in fibrotic lung disease.
Datta A, Alexander R, Sulikowski MG, Nicholson AG, Maher TM, Scotton CJ, Chambers RC. J Immunol. 2013 Nov 1;191(9):4867-79.
Novel therapeutic approaches for pulmonary fibrosis.
Datta A, Scotton CJ, Chambers RC.
Br J Pharmacol. 2011 May;163(1):141-72
Courses offered to GPs
- MBBS University College, London 1999
- BAHons (Cantab) Jesus College, University of Cambridge 1996
- PhD University College, London 2012
- MRCP RCP (London) 2002
Reference number 4641647
Details of entry to specialist register
- Respiratory / General Medicine, 2012
Affiliations / memberships
American Thoracic Society
British Thoracic Society
European Thoracic Society
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.